And that is a pretty remarkable finding. Semaglutide belongs to a family of drugs that mimic the gut hormone GLP-1 ( SN: 8/29/23 )
Men can receive similar care through the Hims telehealth platform
These medications originated to treat type 2 diabetes , and were later approved in the US for weight loss by the Food and Drug Administration (FDA) under Ozempic and Wegovy brand names
This necessitates regular monitoring of thyroid function during active weight loss phases to avoid overtreatment, which can cause symptoms of hyperthyroidism including palpitations, anxiety, and bone loss
As the first GLP-1 receptor agonist available in pill form, it offers an effective, non-injection alternative for appetite regulation, insulin sensitivity, and sustainable weight loss
In controlled laboratory settings, Semaglutide (GLP1-S) is studied for its interaction with the GLP-1 receptor pathway, including downstream effects on insulin signaling, glucagon modulation, and intracellular metabolic regulation mechanisms